Fortrea Holdings Inc. (FTRE) is a Healthcare · Biotechnology company listed on NASDAQ. Price $19.57 (-3.50%), Market cap $1.29B, 52-week low–high $4.06 ~ $18.40.
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical pharmacology, such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling and simulation, and biometrics; and clinical development, including phase I through IV clinical and real-world evidence studies, regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, comprehensive site and medical monitoring, da
Financial statements, price targets, institutional (13F) holdings and related news for Fortrea Holdings Inc. are updated in real time on BlackAll Trade.
Fortrea Holdings Inc. trades at $19.57 (-3.50%). Real-time quotes and charts are available on BlackAll Trade.
Fortrea Holdings Inc. has a market cap of about $1.29B.
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worl